CClinicalTrials.gg
CompletedNCT01133847ICARDUpdated Apr 11, 2017Results posted

Interventions for Children With Attention and Reading Disorders

A Phase 4 interventional study of Methylphenidate and Intensive reading instruction in Attention Deficit Hyperactivity Disorder and Reading Disabilities, sponsored by The University of Texas Health Science Center, Houston. Completed at 2 sites in United States. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2017-04-11.

Sponsored by The University of Texas Health Science Center, Houston · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
222
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) ADHD treatment alone, (b) RD treatment alone, or (c) the combination of ADHD and RD treatment.

Read the detailed description

The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) disorder-specific ADHD treatment (carefully managed medication + parent training), (b) disorder-specific RD treatment (intensive, individualized reading instruction), or (c) the combination of ADHD and RD treatment. The study aims to address the relative benefits of providing either disorder-specific ADHD or RD treatment alone and providing the combined treatment. The investigators hypothesize that the combined treatment approach will result in better outcomes in terms of both word reading/decoding and a reduction in ADHD symptoms than either of the disorder-specific treatments alone. Treatment will last for 16 weeks, with assessment prior to and following treatment and some measures collected regularly throughout the intervention periods.

02

Conditions studied

  • Attention Deficit Hyperactivity Disorder
  • Reading Disabilities
03

In context

Dyslexia

124 studies on the registry are indexed under Dyslexia; 27 are open to participants now.

This study's enrollment of 222 is above the median of 76 across 106 interventional studies indexed under Dyslexia.

Browse Dyslexia studies →

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Meet criteria for ADHD, Combined Type or ADHD, Predominantly Inattentive Type based on the Diagnostic Interview Schedule for Children, 4.0 (DISC) parent interview, Teacher baseline Swanson Nolan and Pelham Rating Scale (SNAP) endorses additional non-overlapping Inattentive symptoms with the parent DISC, which when combined with the parent ratings result in endorsement of 6 or more symptoms required for diagnosis by the Diagnostic and Statistical Manual.
  2. Have at least 4 symptoms of inattention rated "Often" or "Very Often" on the teacher version of the SNAP-IV.
  3. Have a standard score of 90 or lower on either the Woodcock-Johnson III Tests of Achievement Letter-Word Identification or Word Attack Subtests, or on the Basic Reading Skills Cluster
  4. Attend a participating school in Grades 2-5
  5. Have at least one parent or guardian who understands English well enough to participate in the behavioral parent training intervention.
  6. Have a Full Scale OR Non-Verbal Intelligence Quotient (IQ) estimate higher than 70 based on the IQ Composite and Non-Verbal IQ estimate of the Kaufman Brief Intelligence Test (KBIT-2).

Exclusion criteria

Exclusion Criteria:

  1. Any documented or suspected bipolar disorder, severe psychosis, or other severe emotional disturbance, developmental disability, or autism.
  2. Receipt of primary school reading instruction in a language other than English.
  3. A history or presence of cardiovascular problems that would contraindicate stimulant treatment.
  4. Chronic vocal tics.
  5. Children will be excluded if they are taking a concomitant medication that has the potential to significantly affect their ADHD symptoms, that would be contraindicated to take along with the study medication, or if they have not been on a stable dose of a psychotropic medication long enough to fully assess the clinical outcome or tolerability.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
222 participants (actual)

Study arms

  • Experimental
    Intensive Reading Instruction

    Specialized phonologically-based reading instruction provided by well-trained tutors either individually (one-on-one) or to groups of two students for 45 minutes, four days per week, for 16 weeks. The instructional approach includes an individualized combination of published programs targeting word reading and decoding; reading fluency; and reading comprehension.

    Behavioral: Intensive reading instruction

  • Experimental
    ADHD Intervention

    Carefully-managed medication and behavioral parent training. Medication treatment begins with a four-week titration period, beginning with a trial of methylphenidate. If benefit is insufficient or side effects are intolerable, the physician may initiate a trial of mixed salt amphetamine, followed by either Atomoxetine or Guanfacine. When the optimum medication and dosage is determined the child returns for monthly medication maintenance visits until the end of the 16-week intervention period. Parent training consists of nine group sessions provided by a psychologist addressing ADHD and its treatment, principals of behavior modification, and evidence-supported practices for managing behavior.

    Drug: Methylphenidate · Behavioral: Parent Training · Drug: Mixed Salt Amphetamine · Drug: Atomoxetine · Drug: Guanfacine

  • Experimental
    Combined ADHD and Reading Instruction

    All interventions described in Reading Instruction and ADHD treatment arms: Phonologically-based reading instruction provided for 45 minutes, four days per week, for 16 weeks. Carefully-managed medication and behavioral parent training. Medication treatment begins with a trial of methylphenidate. If benefit is insufficient or side effects are intolerable, the physician may initiate a trial of mixed salt amphetamine, followed by either Atomoxetine or Guanfacine. When the optimum medication and dosage is determined the child returns for monthly medication maintenance visits until the end of the 16-week intervention period. Parent training consists of nine group sessions on parenting a child with ADHD.

    Drug: Methylphenidate · Behavioral: Intensive reading instruction · Behavioral: Parent Training · Drug: Mixed Salt Amphetamine · Drug: Atomoxetine · Drug: Guanfacine

Interventions

  • DrugMethylphenidate

    Appropriate dosage to be individually determined; daily for 16 weeks

    Also known as: Concerta Extended Release, Ritalin

  • BehavioralIntensive reading instruction

    Individualized phonologically-based instruction delivered 4 days per week for 45 min. per day by a highly trained tutor.

  • BehavioralParent Training

    Nine sessions on parenting a child with ADHD

  • DrugMixed Salt Amphetamine

    Appropriate dosage to be individually determined; daily for 16 weeks; prescribed only if child does not show a beneficial treatment response to Concerta

    Also known as: Adderall Extended Release (XR)

  • DrugAtomoxetine

    Appropriate dosage to be individually determined; daily for 16 weeks

    Also known as: Strattera

  • DrugGuanfacine

    Appropriate dosage to be individually determined; daily for 16 weeks

    Also known as: Intuniv

06

What researchers measure

Primary outcomes

  1. Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Inattention

    Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).

    Time frame: 16 weeks (end of Active Treatment phase), and follow-up

  2. Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Hyperactivity-impulsivity

    Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).

    Time frame: 16 weeks (end of Active Treatment phase), and follow-up

  3. Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Teacher Rating of Inattention

    Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).

    Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up

  4. Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Teacher Rating of Hyperactivity-impulsivity

    Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).

    Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up

  5. Wechsler Individual Achievement Test-III (WIAT-III) Word Reading Subtest

    The WIAT-III is an individually-administered test of academic achievement. In the Word Reading subtest students read a list of increasingly difficult words. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15.

    Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up

  6. Wechsler Individual Achievement Test-III (WIAT-III) Pseudoword Decoding Subtest

    The WIAT-III is an individually-administered test of academic achievement. In the Pseudoword Decoding subtest students read a list of increasingly difficult nonsense words as a test of their ability to use phonics to decode unknown words. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15. Higher scores represent a better outcome.

    Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up

Secondary outcomes

  1. Wechsler Individual Achievement Test-III (WIAT-III) Reading Comprehension Subtest

    The WIAT-III is an individually-administered test of academic achievement. This subtest involves reading sentences and longer passages and then answering a set of literal and inferential comprehension questions about the text. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15. Higher scores represent a better outcome.

    Time frame: Week 16, End of Active Treatment Phase

  2. Dynamic Indicators of Basic Early Literacy Skills Oral Reading Fluency Subtest (DIBELS ORF)

    DIBELS ORF measures oral reading fluency in connected text. Students are presented with a passage on their grade level to read orally, and the score is the number of words of the passage read correctly in a one-minute period. Students in this study read two passages at each test administration, and the mean score for the two passages was the dependent variable analyzed. A research synthesis of studies reporting psychometric properties for DIBELS ORF determined that reliability coefficients in these studies exceeded .80 and that the measure demonstrated moderate to high concurrent and predictive validity across studies (Goffreda \& DiPerna, 2010).

    Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up

  3. Test of Word Reading Efficiency (TOWRE) - Sight Word Efficiency

    The TOWRE Sight Word Efficiency subtest measures fluency of reading words in lists. The raw score is the number of words or nonwords identified correctly in 45 seconds. Standard scores with a mean of 100 and standard deviaion of 15 are reported here. Higher scores represent a better outcome.

    Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up

  4. Test of Word Reading Efficiency (TOWRE) - Phonemic Decoding Efficiency

    The TOWRE Phonemic Decoding Efficiency measures the student's fluent decoding of nonsense words that follow the spelling rules of the English language. The raw score is the number of nonwords identified correctly in 45 seconds. Standardized scores with a mean of 100 and standard deviaion of 15 are reported here. Higher scores represent a better outcome.

    Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up

  5. Test of Silent Reading Fluency and Comprehension (TOSREC)

    The TOSREC measures sentence-level comprehension and silent reading fluency. It is a sentence verification task; children are presented with a list of sentences and must tell whether they are true or false. Items are based on common knowledge (e.g., All apples are blue). The raw score is the number of items answered correctly in 3 minutes. Standardized with a mean of 100 and standard deviation of 15 are reported here. Higher scores represent a better outcome.

    Time frame: Week 16, End of Active Treatment Phase

07

Results

Posted Apr 11, 2017
Limitations and caveats
There was some non-adherence, particularly for the ADHD treatment. Our oversampling of low income, African American children, although valuable in an understudied population, may limit generalizability.

Participant flow

Active Treatment Phase (Weeks 1-16)
Participant flow — Active Treatment Phase (Weeks 1-16)
MilestoneADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
Started787470
Completed737367
Not completed513
Withdrew: Withdrawal by subject513
Follow-Up Phase
Participant flow — Follow-Up Phase
MilestoneADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
Started737367
Completed727060
Not completed137
Withdrew: Lost to follow-up137

Outcome measures

PrimarySwanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Inattention

Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).

Time frame:
16 weeks (end of Active Treatment phase), and follow-up
Reported as:
Least squares mean · Units on a scale
Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Inattention
Units on a scaleADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-Week Outcomes1.1 ± 0.11.7 ± 0.11.0 ± 0.1
Follow-up Outcomes1.3 ± 0.11.6 ± 0.11.0 ± 0.1
PrimarySwanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Hyperactivity-impulsivity

Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).

Time frame:
16 weeks (end of Active Treatment phase), and follow-up
Reported as:
Least squares mean · units on a scale
Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Hyperactivity-impulsivity
units on a scaleADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-Week Outcomes0.8 ± 0.11.3 ± 0.10.6 ± 0.1
Follow-up Outcomes0.9 ± 0.11.4 ± 0.10.7 ± 0.1
PrimarySwanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Teacher Rating of Inattention

Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).

Time frame:
Week 16 (End of Active Treatment Phase) and Follow-Up
Reported as:
Least squares mean · Units on a scale
Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Teacher Rating of Inattention
Units on a scaleADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-week Outcomes1.2 ± 0.11.7 ± 0.11.4 ± 0.1
Follow-Up1.5 ± 0.11.9 ± 0.11.5 ± 0.1
PrimarySwanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Teacher Rating of Hyperactivity-impulsivity

Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).

Time frame:
Week 16 (End of Active Treatment Phase) and Follow-Up
Reported as:
Least squares mean · Units on a scale
Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Teacher Rating of Hyperactivity-impulsivity
Units on a scaleADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-Week Outcomes0.7 ± 0.11.1 ± 0.10.8 ± 0.1
Follow-up0.8 ± 0.11.1 ± 0.10.8 ± 0.1
PrimaryWechsler Individual Achievement Test-III (WIAT-III) Word Reading Subtest

The WIAT-III is an individually-administered test of academic achievement. In the Word Reading subtest students read a list of increasingly difficult words. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15.

Time frame:
Week 16 (End of Active Treatment Phase) and Follow-Up
Reported as:
Least squares mean · standardized scores, M=100, SD = 15
Wechsler Individual Achievement Test-III (WIAT-III) Word Reading Subtest
standardized scores, M=100, SD = 15ADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-Week Outcomes76.9 ± 0.779.0 ± 0.779.9 ± 0.7
Follow-Up77.1 ± 0.878.1 ± 0.878.8 ± 0.8
PrimaryWechsler Individual Achievement Test-III (WIAT-III) Pseudoword Decoding Subtest

The WIAT-III is an individually-administered test of academic achievement. In the Pseudoword Decoding subtest students read a list of increasingly difficult nonsense words as a test of their ability to use phonics to decode unknown words. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15. Higher scores represent a better outcome.

Time frame:
Week 16 (End of Active Treatment Phase) and Follow-Up
Reported as:
Least squares mean · standardized scores
Wechsler Individual Achievement Test-III (WIAT-III) Pseudoword Decoding Subtest
standardized scoresADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-Week Outcomes78.3 ± 1.083.8 ± 1.083.0 ± 1.1
Follow-Up77.1 ± 1.082.6 ± 1.181.9 ± 1.2
SecondaryWechsler Individual Achievement Test-III (WIAT-III) Reading Comprehension Subtest

The WIAT-III is an individually-administered test of academic achievement. This subtest involves reading sentences and longer passages and then answering a set of literal and inferential comprehension questions about the text. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15. Higher scores represent a better outcome.

Time frame:
Week 16, End of Active Treatment Phase
Reported as:
Least squares mean · standardized scores
Wechsler Individual Achievement Test-III (WIAT-III) Reading Comprehension Subtest
standardized scoresADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
Wechsler Individual Achievement Test-III (WIAT-III) Reading Comprehension Subtest88.27 ± 0.984.70 ± 0.986.35 ± 1.0
SecondaryDynamic Indicators of Basic Early Literacy Skills Oral Reading Fluency Subtest (DIBELS ORF)

DIBELS ORF measures oral reading fluency in connected text. Students are presented with a passage on their grade level to read orally, and the score is the number of words of the passage read correctly in a one-minute period. Students in this study read two passages at each test administration, and the mean score for the two passages was the dependent variable analyzed. A research synthesis of studies reporting psychometric properties for DIBELS ORF determined that reliability coefficients in these studies exceeded .80 and that the measure demonstrated moderate to high concurrent and predictive validity across studies (Goffreda \& DiPerna, 2010).

Time frame:
Week 16 (End of Active Treatment Phase) and Follow-Up
Reported as:
Mean · words read correctly per minute
Dynamic Indicators of Basic Early Literacy Skills Oral Reading Fluency Subtest (DIBELS ORF)
words read correctly per minuteADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-Week Outcomes53.67 ± 30.350.71 ± 31.9453.83 ± 33.5
Follow-Up63.06 ± 31.9757.40 ± 31.0659.05 ± 31.97
SecondaryTest of Word Reading Efficiency (TOWRE) - Sight Word Efficiency

The TOWRE Sight Word Efficiency subtest measures fluency of reading words in lists. The raw score is the number of words or nonwords identified correctly in 45 seconds. Standard scores with a mean of 100 and standard deviaion of 15 are reported here. Higher scores represent a better outcome.

Time frame:
Week 16 (End of Active Treatment Phase) and Follow-Up
Reported as:
Least squares mean · standardized scores
Test of Word Reading Efficiency (TOWRE) - Sight Word Efficiency
standardized scoresADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-Week Outcomes80.8 ± 0.8282.7 ± 0.8283.5 ± 0.87
Follow-Up83.57 ± 0.8285.04 ± 0.8484.15 ± 0.90
SecondaryTest of Word Reading Efficiency (TOWRE) - Phonemic Decoding Efficiency

The TOWRE Phonemic Decoding Efficiency measures the student's fluent decoding of nonsense words that follow the spelling rules of the English language. The raw score is the number of nonwords identified correctly in 45 seconds. Standardized scores with a mean of 100 and standard deviaion of 15 are reported here. Higher scores represent a better outcome.

Time frame:
Week 16 (End of Active Treatment Phase) and Follow-Up
Reported as:
Least squares mean · standardized scores
Test of Word Reading Efficiency (TOWRE) - Phonemic Decoding Efficiency
standardized scoresADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
16-Week Outcomes80.4 ± 0.7983.4 ± 0.7982.9 ± 0.84
Follow-Up81.49 ± 0.8384.50 ± 0.8684.32 ± 0.92
SecondaryTest of Silent Reading Fluency and Comprehension (TOSREC)

The TOSREC measures sentence-level comprehension and silent reading fluency. It is a sentence verification task; children are presented with a list of sentences and must tell whether they are true or false. Items are based on common knowledge (e.g., All apples are blue). The raw score is the number of items answered correctly in 3 minutes. Standardized with a mean of 100 and standard deviation of 15 are reported here. Higher scores represent a better outcome.

Time frame:
Week 16, End of Active Treatment Phase
Reported as:
Least squares mean · standardized scores
Test of Silent Reading Fluency and Comprehension (TOSREC)
standardized scoresADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
Test of Silent Reading Fluency and Comprehension (TOSREC)17.40 ± 0.717.70 ± 0.718.57 ± 0.75

Adverse events

Collected over 6 years. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
ADHD Treatment—0/71 (0%)3/71 (4.2%)
Intensive Reading Instruction—0/74 (0%)1/74 (1.4%)
Combined ADHD Treatment and Reading Instruction—0/68 (0%)5/68 (7.4%)
Most frequent other events
Most frequent other events
EventADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading Instruction
Aggressive behaviorsSocial circumstances3/711/745/68

Baseline characteristics

Baseline characteristics are for our final analysis sample, consisting of all children randomized to each condition except for 1 in the ADHD arm, 1 in the Reading arm, and 4 in the Combined arm, who were excluded because upon ex post-facto review of records, they did not meet either ADHD, RD, or IQ inclusion criteria and had been included in error.

Age, Categorical
Age, Categorical(Participants)ADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading InstructionTotal
<=18 years777366216
Between 18 and 65 years0000
>=65 years0000
Sex: Female, Male
Sex: Female, Male(Participants)ADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading InstructionTotal
Female25243584
Male524931132
Region of Enrollment
Region of Enrollment(participants)ADHD TreatmentIntensive Reading InstructionCombined ADHD Treatment and Reading InstructionTotal
United States777366216
08

Study locations

2 sites
  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45206, United States
  • University of Texas Health Science Center
    Houston, Texas 77030, United States
09

References and documents

Publications

  • Dvorsky M, Tamm L, Denton CA, Epstein JN, Schatschneider C. Trajectories of Response to Treatments in Children with ADHD and Word Reading Difficulties. Res Child Adolesc Psychopathol. 2021 Aug;49(8):1015-1030. doi: 10.1007/s10802-021-00815-y. Epub 2021 Mar 26. PubMed 33772416 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01133847
Lead sponsor
The University of Texas Health Science Center, Houston
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Children's Hospital Medical Center, Cincinnati
Responsible party
Carolyn Denton (Professor - Pediatrics, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
May 31, 2010
Start date
Nov 2010
Primary completion
Jun 2015
Completion
Jun 2015
Results posted
Apr 11, 2017
Last update
Apr 11, 2017

Study contacts

Carolyn A Denton, Ph.D.
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion